These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 17926883
21. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K. N Engl J Med; 1994 Nov 24; 331(21):1397-402. PubMed ID: 7969278 [Abstract] [Full Text] [Related]
22. Measles, mumps and rubella: control by vaccination. van Druten JA, de Boo T, Plantinga AD. Dev Biol Stand; 1986 Nov 24; 65():53-63. PubMed ID: 3556777 [Abstract] [Full Text] [Related]
23. [Maternal mortality and perinatal mortality]. Boutaleb Y, Mesbahi M, Lahlou D, Aderdour M. J Gynecol Obstet Biol Reprod (Paris); 1982 Nov 24; 11(1):99-102. PubMed ID: 7201485 [Abstract] [Full Text] [Related]
24. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Zäch K, Nicoara C, Germann D, Matter L. Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837 [Abstract] [Full Text] [Related]
25. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid]. Gil Miguel A, Astasio Arbiza P, Ortega Molina P, Domínguez Rojas V, González López A. An Esp Pediatr; 1999 May 25; 50(5):459-62. PubMed ID: 10394183 [Abstract] [Full Text] [Related]
26. [PRENATAL VIRUS INFECTIONS]. THALHAMMER O. Med Klin; 1963 Sep 27; 58():1586-91. PubMed ID: 14049623 [No Abstract] [Full Text] [Related]
28. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D. Pediatrics; 2006 Jul 27; 118(1):e139-50. PubMed ID: 16818529 [Abstract] [Full Text] [Related]
29. [PERINATAL MORTALITY IN MATERNAL INFECTIONS]. UHER M, UHLIR M, BEDNAR A. Cesk Gynekol; 1964 Aug 27; 29():562-7. PubMed ID: 14201282 [No Abstract] [Full Text] [Related]
30. Evaluation of potentially common adverse events associated with the first and second doses of measles-mumps-rubella vaccine. LeBaron CW, Bi D, Sullivan BJ, Beck C, Gargiullo P. Pediatrics; 2006 Oct 27; 118(4):1422-30. PubMed ID: 17015532 [Abstract] [Full Text] [Related]
31. Combination measles, mumps, rubella and varicella vaccine. Arbeter AM, Baker L, Starr SE, Levine BL, Books E, Plotkin SA. Pediatrics; 1986 Oct 27; 78(4 Pt 2):742-7. PubMed ID: 3763291 [Abstract] [Full Text] [Related]
32. [Danger for the human embryo resulting from viruses]. Töndury G. Geburtshilfe Frauenheilkd; 1965 Nov 27; 25(11):997-1028. PubMed ID: 5885837 [No Abstract] [Full Text] [Related]
34. [Initial results and evaluation of igg antibody levels for measles, mumps, rubella and chickenpox viruses in young adults born in 1989]. Sadowska-Galera M. Przegl Epidemiol; 2009 Nov 27; 63(3):363-7. PubMed ID: 19899592 [Abstract] [Full Text] [Related]
37. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Zignol M, Peracchi M, Tridello G, Pillon M, Fregonese F, D'Elia R, Zanesco L, Cesaro S. Cancer; 2004 Aug 01; 101(3):635-41. PubMed ID: 15274078 [Abstract] [Full Text] [Related]
38. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants. D'Angio CT, Boohene PA, Mowrer A, Audet S, Menegus MA, Schmid DS, Beeler JA. Pediatrics; 2007 Mar 01; 119(3):e574-9. PubMed ID: 17332177 [Abstract] [Full Text] [Related]